Elaine D Sun is Director of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 47,557 shares of RXRX, which is worth approximately $265,843. The most recent transaction as insider was on Jun 18, 2025, when has been sold 11,008 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 47.6K
30.12% 3M change
n/a 12M change
Total Value Held $265,843

Elaine D Sun Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 18 2025
BUY
Grant, award, or other acquisition
-
11,008 Added 18.8%
47,557 Class A Common Stock
Mar 17 2025
BUY
Grant, award, or other acquisition
-
36,549 Added 50.0%
36,549 Class A Common Stock

Also insider at

HALO
HALOZYME THERAPEUTICS, INC. Healthcare
DVAX
DYNAVAX TECHNOLOGIES CORP Healthcare
EDS

Elaine D Sun

Director
San Diego, CA

Track Institutional and Insider Activities on RXRX

Follow RECURSION PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Track Activities on RXRX